VivoSim Labs share price logo

VivoSim Labs

NASDAQ: ONVO

$2.00

-0.01

(-0.50%)

as on

Bell Icon

This instrument is not available for trading on the INDmoney app on 21 Apr 2025

VivoSim Labs Stock Performance

as on April 24, 2025 at 5:25 am IST

  • $2.00
    $2.00
  • 52 Week's Low

    52 Week's High

    $1.56
    $1.77
    downward going graph

    22.00%

    Downside

    -11.50%

    Upside

    downward going graph

VivoSim Labs share price movements today

Previous Close
$2.01
Open
$2.00
Volume
6.6K
Day's Low - High
$2.00 - $2.00
52 Week Low - High
$1.56 - $1.77

VivoSim Labs Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

VivoSim Labs Stock Fundamentals & Key Indicators

Check VivoSim Labs market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0.00

Return On Equity TTM

0.00%

VivoSim Labs stock Key Stats

Compare market cap, revenue, PE, and other key metrics of VivoSim Labs with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Hold$-NANA0.00%0.00%

Analyst Recommendation on VivoSim Labs Stock

Based on 7 analysts

HOLD

0.00%

Buy

57.14%

Hold

42.86%

Sell

Based on 7 analysts, 57.14% of analysts recommend a 'HOLD' rating for VivoSim Labs. Average target price of $64.8

VivoSim Labs Share Price Target

Get share price movements and forecasts by analysts on VivoSim Labs.

What analysts predicted

96.91%UPSIDE

Target Price

$64.8

Current Price

$2

Analyzed by

7 Analysts

Target

$64.80

VivoSim Labs target price $64.8, a slight upside of 96.91% compared to current price of $2. According to 7 analysts rating.

VivoSim Labs Quarterly Profit & Loss

All numbers in Millions USD

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Total Revenue
0
0
0
0
-
0
0
0
0
0
Gross Profit
0
0
-
0
0
0
0
0
0
0
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-3
-3
-7
-4
-3
-3
-3
-3
-2
-3
Net Profit Margin
-4179.22%
-2419.08%
-4604.32%
-5370.67%
0.00%
-72080.00%
-10500.00%
-8574.36%
-8496.67%
-14362.50%

VivoSim Labs Annual Profit & Loss

All numbers in Millions USD

Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Total Revenue
0
1
4
4
3
2
-
1
0
0
Gross Profit
-12
-16
3
3
2
1
0
1
0
0
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-30
-38
-38
-34
-26
-18
-16
-11
-17
-14
Net Profit Margin
-5268.30%
-2601.15%
-908.91%
-756.09%
-861.70%
-852.00%
0.00%
-763.20%
-4664.59%
-13459.63%

Global Institutional Holdings in VivoSim Labs

Check out the Institutions with significant holdings in VivoSim Labs.

Funds
Holdings
Hanson Mcclain Inc
0.01%
Armistice Capital, LLC
7.59%
Tower Research Capital LLC
0.01%
SBI Securities Co Ltd
0.01%
Geode Capital Management, LLC
0.56%

About VivoSim Labs

Organovo Holdings, Inc. is a clinical-stage biotechnology company. The Company is developing drugs that are demonstrated to be effective in three-dimensional (3D) human tissues as candidates for drug development. It focuses on developing novel treatment approaches in inflammatory bowel disease (IBD). The Company has proprietary technology used to build 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. It uses its proprietary technology to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. Its Mosaic division to serve as a key source of certain primary human cells it utilizes in its research and development efforts. Its 3D human tissue platform is multifaceted. Its NovoGen Bioprinters can also dispense pure hydrogel formulations, provided the physical properties of the hydrogel are compatible with the dispensing parameters.
OrganisationVivoSim Labs

FAQs

What is VivoSim Labs share price today?

VivoSim Labs share price today is $2.00 as on at the close of the market. VivoSim Labs share today touched a day high of $2.00 and a low of $2.00.

What is the 52 week high and 52 week low for VivoSim Labs share?

VivoSim Labs share touched a 52 week high of $1.77 on and a 52 week low of $1.56 on . VivoSim Labs stock price today i.e. is closed at $2.00,which is -12.99% down from its 52 week high and 28.21% up from its 52 week low.

How to invest in VivoSim Labs Stock (ONVO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for VivoSim Labs on INDmoney app. Click on Buy button.

What is the minimum amount required to buy VivoSim Labs Stock (ONVO) from India?

Indian investors can start investing in VivoSim Labs (ONVO) shares with as little as ₹93.91000366210938 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹939.10 in VivoSim Labs stock (as per the Rupee-Dollar exchange rate as on ). Based on VivoSim Labs share’s latest price of $2.00 as on April 23, 2025 at 11:55 pm IST, you will get 5.0000 shares of VivoSim Labs. Learn more about fractional shares .